- Home
- CREX vs CURX Comparison
CREX vs CURX Comparison
Compare CREX & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREX
- CURX
- Stock Information
- Founded
- CREX N/A
- CURX 2018
- Country
- CREX United States
- CURX United States
- Employees
- CREX N/A
- CURX N/A
- Industry
- CREX EDP Services
- CURX Biotechnology: Pharmaceutical Preparations
- Sector
- CREX Technology
- CURX Health Care
- Exchange
- CREX Nasdaq
- CURX Nasdaq
- Market Cap
- CREX 33.2M
- CURX 29.7M
- IPO Year
- CREX N/A
- CURX 2025
- Fundamental
- Price
- CREX $2.63
- CURX $0.50
- Analyst Decision
- CREX Strong Buy
- CURX
- Analyst Count
- CREX 1
- CURX 0
- Target Price
- CREX $6.00
- CURX N/A
- AVG Volume (30 Days)
- CREX 80.3K
- CURX 2.7M
- Earning Date
- CREX 11-12-2025
- CURX 09-09-2025
- Dividend Yield
- CREX N/A
- CURX N/A
- EPS Growth
- CREX N/A
- CURX N/A
- EPS
- CREX N/A
- CURX N/A
- Revenue
- CREX $44,323,000.00
- CURX N/A
- Revenue This Year
- CREX N/A
- CURX N/A
- Revenue Next Year
- CREX $24.88
- CURX N/A
- P/E Ratio
- CREX N/A
- CURX N/A
- Revenue Growth
- CREX N/A
- CURX N/A
- 52 Week Low
- CREX $1.28
- CURX $3.61
- 52 Week High
- CREX $4.00
- CURX $8.60
- Technical
- Relative Strength Index (RSI)
- CREX 42.92
- CURX N/A
- Support Level
- CREX $2.45
- CURX N/A
- Resistance Level
- CREX $2.96
- CURX N/A
- Average True Range (ATR)
- CREX 0.18
- CURX 0.00
- MACD
- CREX -0.05
- CURX 0.00
- Stochastic Oscillator
- CREX 23.65
- CURX 0.00
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.
About CURX Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.